All protocols approved by the Institutional Biosafety Committee (IBC) for which the departing investigator is designated as the PI must be terminated, or an alternate PI should be designated via a protocol modification form. The IBC Division can provide further details about these procedures. Contact the IBC Division at (412) 383-1768 or IBC_Support@pitt.edu.
- About
- Training
- Required Training
- Research Specific Training
- Biosafety and Biosecurity
- Use of Controlled Substances in Basic and Animal Research
- Clinical Research Coordinator
- Clinical Trial Billing Compliance
- ClinicalTrials.gov
- Environmental Health & Safety (EHS)
- Export Controls
- Good Clinical Practice (GCP)
- Good Laboratory Practice
- Humanitarian Use Device (HUD)
- Human Stem Cell Oversight
- International Research
- Privacy & Information Security for Researchers
- Radiation Safety
- Research with Children
- Training Table
- Collaborative Institutional Training Initiative (CITI)
- Video Presentations Library
- Resources
- Events
- NEWS
- People
- Contact
- Report a Concern